These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1012 related items for PubMed ID: 11778797

  • 1. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
    Chetta A, Pisi G, Zanini A, Foresi A, Grzincich GL, Aiello M, Battistini A, Olivieri D.
    Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
    [Abstract] [Full Text] [Related]

  • 2. Factors that correlate with sleep oxygenation in children with cystic fibrosis.
    Uyan ZS, Ozdemir N, Ersu R, Akpinar I, Keskin S, Cakir E, Karadağ B, Karakoç F, Dağli E.
    Pediatr Pulmonol; 2007 Aug; 42(8):716-22. PubMed ID: 17595040
    [Abstract] [Full Text] [Related]

  • 3. Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease.
    Chetta A, Aiello M, Foresi A, Marangio E, D'Ippolito R, Castagnaro A, Olivieri D.
    Sarcoidosis Vasc Diffuse Lung Dis; 2001 Jun; 18(2):170-5. PubMed ID: 11436537
    [Abstract] [Full Text] [Related]

  • 4. Reference values for the 6-min walk test in healthy subjects 20-50 years old.
    Chetta A, Zanini A, Pisi G, Aiello M, Tzani P, Neri M, Olivieri D.
    Respir Med; 2006 Sep; 100(9):1573-8. PubMed ID: 16466676
    [Abstract] [Full Text] [Related]

  • 5. The six-minute walking test in children with cystic fibrosis: reliability and validity.
    Gulmans VA, van Veldhoven NH, de Meer K, Helders PJ.
    Pediatr Pulmonol; 1996 Aug; 22(2):85-9. PubMed ID: 8875580
    [Abstract] [Full Text] [Related]

  • 6. Predicting survival in end-stage cystic fibrosis.
    Ketchell RI, Roughton M, Agent P, Gyi K, Hodson ME.
    Respir Med; 2009 Oct; 103(10):1441-7. PubMed ID: 19615875
    [Abstract] [Full Text] [Related]

  • 7. Six-minute walk test in children and adolescents with cystic fibrosis.
    Cunha MT, Rozov T, de Oliveira RC, Jardim JR.
    Pediatr Pulmonol; 2006 Jul; 41(7):618-22. PubMed ID: 16703573
    [Abstract] [Full Text] [Related]

  • 8. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients.
    Chuang ML, Lin IF, Wasserman K.
    Respir Med; 2001 Jul; 95(7):618-26. PubMed ID: 11453321
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of six minute walk test in cystic fibrosis adults.
    Martin C, Chapron J, Hubert D, Kanaan R, Honoré I, Paillasseur JL, Aubourg F, Dinh-Xuan AT, Dusser D, Fajac I, Burgel PR.
    Respir Med; 2013 Dec; 107(12):1881-7. PubMed ID: 24157200
    [Abstract] [Full Text] [Related]

  • 10. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
    Modrykamien AM, Gudavalli R, McCarthy K, Parambil J.
    Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
    [Abstract] [Full Text] [Related]

  • 11. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).
    Fujimoto H, Asai K, Watanabe T, Kanazawa H, Hirata K.
    Osaka City Med J; 2011 Jun; 57(1):21-9. PubMed ID: 22106764
    [Abstract] [Full Text] [Related]

  • 12. [The six minute walking test elicits lung hyperinflation in patients with severe chronic obstructive lung disease].
    Reid R, Díaz O, Jorquera J, Lisboa C.
    Rev Med Chil; 2001 Oct; 129(10):1171-8. PubMed ID: 11775344
    [Abstract] [Full Text] [Related]

  • 13. Relationship between 6-minute walk test and pulmonary function test in stable chronic obstructive pulmonary disease with different severities.
    Chen H, Liang BM, Tang YJ, Xu ZB, Wang K, Yi Q, Ou XM, Feng YL.
    Chin Med J (Engl); 2012 Sep; 125(17):3053-8. PubMed ID: 22932179
    [Abstract] [Full Text] [Related]

  • 14. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC, Highland KB, Silver RM, Strange C.
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [Abstract] [Full Text] [Related]

  • 15. Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease.
    Falk B, Nini A, Zigel L, Yahav Y, Aviram M, Rivlin J, Bentur L, Avital A, Dotan R, Blau H.
    Pediatr Pulmonol; 2006 Mar; 41(3):234-41. PubMed ID: 16429430
    [Abstract] [Full Text] [Related]

  • 16. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M, Sarzi-Puttini P, Airoldi A, Antivalle M, Battellino M, Atzeni F.
    Clin Exp Rheumatol; 2015 Mar; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [Abstract] [Full Text] [Related]

  • 17. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.
    Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Ogawa T, Watanabe F, Arizono S.
    Respir Med; 2007 Apr; 101(4):833-8. PubMed ID: 16962758
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.
    Golpe R, Pérez-de-Llano LA, Méndez-Marote L, Veres-Racamonde A.
    Respir Care; 2013 Aug; 58(8):1329-34. PubMed ID: 23322886
    [Abstract] [Full Text] [Related]

  • 19. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
    Jorquera J, Díaz O, Lisboa C.
    Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
    [Abstract] [Full Text] [Related]

  • 20. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
    Ijiri N, Kanazawa H, Yoshikawa T, Hirata K.
    Int J Chron Obstruct Pulmon Dis; 2014 Jun; 9():1235-40. PubMed ID: 25395845
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 51.